FutureChem Co.,Ltd

A220100

KR7220100002

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-20 EDT			5-day change	1st Jan Change
14,010 ^KRW	-1.48%		+18.93%	+32.80%

2023	FutureChem Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2023	FutureChem Healthcare announced that it has received KRW 7.500000097 billion in funding from FutureChem Co.,Ltd	CI

FutureChem. Co., Ltd. announced that it has received KRW 2 billion in funding

May 19, 2016

On May 20, 2016, FutureChem. Co., Ltd. closed the transaction.

Latest news about FutureChem Co.,Ltd

FutureChem Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
FutureChem Healthcare announced that it has received KRW 7.500000097 billion in funding from FutureChem Co.,Ltd	23-02-27	CI
FutureChem Healthcare announced that it expects to receive KRW 7.500000097 billion in funding from FutureChem Co.,Ltd	23-02-08	CI
FutureChem Co.,Ltd(KOSDAQ:A220100) added to S&P Global BMI Index	21-09-20	CI
FutureChem Enters into Research Agreement with the University of Colombia for the Parkinson's Diagnostic Radiopharmaceutical	19-06-20	CI
FutureChem Co.,Ltd announced that it has received KRW 30 billion in funding from Nau IB Capital, Investment Arm	18-03-28	CI
FutureChem Co.,Ltd announced that it expects to receive KRW 30 billion in funding from Nau IB Capital, Investment Arm	18-03-25	CI
Kai Health Care Co., Ltd. announced that it has received KRW 5 billion in funding from FutureChem Co.,Ltd	17-09-12	CI
FutureChem Co.,Ltd completed the acquisition of Kai Health Care Co., Ltd. from New Korea Industrial Co. Ltd.	17-09-12	CI
FutureChem Co.,Ltd agreed to acquire Kai Health Care Co., Ltd. from New Korea Industrial Co. Ltd. for KRW 10 billion.	17-09-06	CI
Kai Health Care Co., Ltd. announced that it expects to receive KRW 5 billion in funding from FutureChem Co.,Ltd	17-09-06	CI
FutureChem Plans Listing On KOSDAQ	16-08-29	CI
FutureChem. Co., Ltd. announced that it has received KRW 2 billion in funding	16-05-19	CI
FutureChem. Co., Ltd. announced that it expects to receive KRW 2 billion in funding	16-05-17	CI

FutureChem. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The Company manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer and for the early diagnosis of Parkinson's disease and Alzheimer's disease. The Company also produces medical automation modules such as cubes and disposable goods including disposable cassettes, reagent kits, radio-caps and kryptofix kits; productions of photon emission tomography (PET) and single photon emission computed tomography (SPECT) precursors for radiopharmaceuticals and other chemicals such as metal chelating agents, fluorescence probes, peptides.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
FUTURECHEM CO.,LTD	+32.80%	231M
BIOMÉRIEUX	-6.26%	12.23B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-3.93%	8.17B
DIASORIN S.P.A.	+7.10%	5.78B
LANTHEUS HOLDINGS, INC.	+30.53%	5.74B
AUTOBIO DIAGNOSTICS CO., LTD.	-7.47%	4.24B
10X GENOMICS, INC.	-56.63%	2.97B
ANDON HEALTH CO., LTD.	+12.56%	2.73B
VITROLIFE AB	-4.67%	2.38B
MYRIAD GENETICS, INC.	+27.88%	2.26B

Diagnostic & Testing Substances